Silverback Therapeutics, Inc. Human Resources Contracts & Agreements
19 Contracts & Agreements
- Bonus & Incentive Agreements (3 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (3)
- Consulting Agreements (6)
- Employment Agreements (6)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 21, 2024)
- Executive Employment Agreement, by and between the Company and Brian T. Dorsey, effective as of October 1, 2018 (Filed With SEC on December 9, 2022)
- Consulting Agreement, by and between ARS Pharmaceuticals, Inc. and Pacific-Link Regulatory Consulting, Inc., dated July 1, 2022 (Filed With SEC on November 8, 2022)
- Consulting Agreement, by and between ARS Pharmaceuticals, Inc. and Marlinspike Group, LLC, dated September 14, 2018 (Filed With SEC on November 8, 2022)
- Consulting Agreement, dated as of April 26, 2021, by and between ARS Pharmaceuticals, Inc. and Brenton L. Saunders, as amended on April 25, 2022 (Filed With SEC on November 8, 2022)
- Executive Employment Agreement, dated as of June 1, 2019, by and between ARS Pharmaceuticals, Inc. and Justin Chakma (Filed With SEC on November 8, 2022)
- Executive Employment Agreement, dated as of February 16, 2022, by and between ARS Pharmaceuticals, Inc. and Eric Karas (Filed With SEC on November 8, 2022)
- Executive Employment Agreement, dated as of September 14, 2018, by and between ARS Pharmaceuticals, Inc. and Dr. Sarina Tanimoto, as amended by Amendment No. 1 to Executive... (Filed With SEC on November 8, 2022)
- Executive Employment Agreement, dated as of February 9, 2022, by and between ARS Pharmaceuticals, Inc. and Kathleen Scott (Filed With SEC on November 8, 2022)
- Executive Employment Agreement, dated as of September 14, 2018, by and between ARS Pharmaceuticals, Inc. and Richard E. Lowenthal (Filed With SEC on November 8, 2022)
- Consulting Services Agreement and Statement of Work No. 1, by and between the registrant and Jonathan Piazza, dated September 2, 2022 (Filed With SEC on November 2, 2022)
- Consulting Services Agreement and Statement of Work No. 1, by and between the registrant and Valerie Odegard, dated September 2, 2022 (Filed With SEC on November 2, 2022)
- Consulting Services Agreement and Statement of Work No. 1, by and between the registrant and Laura Shawver, Ph.D., dated September 2, 2022 (Filed With SEC on November 2, 2022)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 12, 2022)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Silverback Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 31, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on November 30, 2020)
- Silverback Therapeutics, Inc. 2020 Equity Incentive Plan, and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on November 30, 2020)
- Silverback Therapeutics, Inc. 2020 Change in Control and Severance Benefit Plan (Filed With SEC on November 10, 2020)
- Silverback Therapeutics, Inc. 2016 Equity Incentive Plan, as amended, and Forms of Option Agreement, Notice of Exercise, Notice of Early Exercise, Restricted Stock Grant Notice... (Filed With SEC on November 10, 2020)
